Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 64

1.

Clinical effects of chemoradiotherapy in pursuit of optimal treatment of locally advanced unresectable pancreatic cancer.

Sui K, Okabayashi T, Shima Y, Morita S, Iwata J, Sumiyoshi T, Saisaka Y, Hata Y, Noda Y, Matsumoto M, Nishioka A, Iiyama T, Shimada Y.

Br J Radiol. 2017 Jul;90(1075):20170165. doi: 10.1259/bjr.20170165. Epub 2017 Jun 7.

2.

Is a surgical approach justified for octogenarians with pancreatic carcinoma? Projecting surgical decision making for octogenarian patients.

Okabayashi T, Shima Y, Iwata J, Morita S, Sumiyoshi T, Kozuki A, Iiyama T, Nishioka A, Matsumoto M.

Am J Surg. 2016 Nov;212(5):896-902. doi: 10.1016/j.amjsurg.2015.12.033. Epub 2016 May 11.

PMID:
27262755
3.

Therapeutic response to a novel enzyme-targeting radiosensitization treatment (Kochi Oxydol-Radiation Therapy for Unresectable Carcinomas) in patients with recurrent breast cancer.

Aoyama N, Ogawa Y, Yasuoka M, Takahashi M, Iwasa H, Miyatake K, Yamanishi T, Hamada N, Tamura T, Nishioka A, Yamagami T.

Oncol Lett. 2016 Jul;12(1):29-34. Epub 2016 May 16.

4.

Short-term Outcomes of Hand-sewn Stump Closure after Distal Pancreatectomy at a Single Institution.

Okabayashi T, Shima Y, Iwata J, Morita S, Sumiyoshi T, Kozuki A, Tokumaru T, Saisaka Y, Iiyama T, Noda Y, Hata Y, Nishioka A, Matsumoto M.

Am Surg. 2016 Mar;82(3):E60-2. No abstract available.

PMID:
27099046
5.
6.

Clinicopathological features and surgical outcomes of intraductal tubulopapillary neoplasm of the pancreas: a systematic review.

Date K, Okabayashi T, Shima Y, Iwata J, Sumiyoshi T, Kozuki A, Morita S, Hata Y, Noda Y, Nishioka A, Matsumoto M.

Langenbecks Arch Surg. 2016 Jun;401(4):439-47. doi: 10.1007/s00423-016-1391-6. Epub 2016 Mar 21. Review.

PMID:
27001682
7.

The Japanese Breast Cancer Society Clinical Practice Guideline for radiation treatment of breast cancer, 2015 edition.

Yamauchi C, Sekiguchi K, Nishioka A, Arahira S, Yoshimura M, Ogo E, Oguchi M, Ito Y, Mukai H.

Breast Cancer. 2016 May;23(3):378-90. doi: 10.1007/s12282-016-0672-9. Epub 2016 Feb 16. No abstract available.

PMID:
26883534
8.

Development of a Novel Enzyme-Targeting Radiosensitizer (New KORTUC) Using a Gelatin-Based Hydrogel Instead of a Sodium Hyaluronate.

Morita-Tokuhiro S, Ogawa Y, Yokota N, Tsuzuki A, Oda H, Ishida N, Aoyama N, Nishioka A.

Cancers (Basel). 2016 Jan 7;8(1). pii: E10. doi: 10.3390/cancers8010010.

9.

Serial Assessment of Therapeutic Response to a New Radiosensitization Treatment, Kochi Oxydol-Radiation Therapy for Unresectable Carcinomas, Type II (KORTUC II), in Patients with Stage I/II Breast Cancer Using Breast Contrast-Enhanced Magnetic Resonance Imaging.

Yaogawa S, Ogawa Y, Morita-Tokuhiro S, Tsuzuki A, Akima R, Itoh K, Morio K, Yasunami H, Onogawa M, Kariya S, Nogami M, Nishioka A, Miyamura M.

Cancers (Basel). 2015 Dec 22;8(1). pii: E1. doi: 10.3390/cancers8010001.

10.

Non-Surgical Breast-Conserving Treatment (KORTUC-BCT) Using a New Radiosensitization Method (KORTUC II) for Patients with Stage I or II Breast Cancer.

Ogawa Y, Kubota K, Aoyama N, Yamanishi T, Kariya S, Hamada N, Nogami M, Nishioka A, Onogawa M, Miyamura M.

Cancers (Basel). 2015 Nov 17;7(4):2277-89. doi: 10.3390/cancers7040891.

11.

Reduction of fibroproliferative changes in irradiated rat lung with soluble transforming growth factor-β receptor.

Nishioka A, Ogawa Y, Kariya S, Hamada N, Nogami M, Inomata T, Ueno H.

Mol Med Rep. 2015 Apr;11(4):2659-63. doi: 10.3892/mmr.2014.3064. Epub 2014 Dec 9.

PMID:
25502978
12.

Safety and efficacy of image-guided enzyme-targeting radiosensitization and intraoperative radiotherapy for locally advanced unresectable pancreatic cancer.

Nishioka A, Ogawa Y, Miyatake K, Tadokoro M, Nogami M, Hamada N, Kubota K, Kariya S, Kohsaki T, Saibara T, Okabayashi T, Hanazaki K.

Oncol Lett. 2014 Jul;8(1):404-408. Epub 2014 Apr 28.

13.

Early prediction of response to neoadjuvant chemotherapy in patients with breast cancer using diffusion-weighted imaging and gray-scale ultrasonography.

Iwasa H, Kubota K, Hamada N, Nogami M, Nishioka A.

Oncol Rep. 2014 Apr;31(4):1555-60. doi: 10.3892/or.2014.3025. Epub 2014 Feb 18.

14.

Correlation of liver parenchymal gadolinium-ethoxybenzyl diethylenetriaminepentaacetic acid enhancement and liver function in humans with hepatocellular carcinoma.

Kubota K, Tamura T, Aoyama N, Nogami M, Hamada N, Nishioka A, Ogawa Y.

Oncol Lett. 2012 May;3(5):990-994. Epub 2012 Mar 1.

15.

Power Doppler and gray-scale sonography standardized by BI-RADS for the differentiation of benign postoperative lesion and local recurrence after breast-conserving therapy.

Kubota K, Iwasa H, Aoyama N, Hamada N, Nogami M, Tamura T, Nishioka A, Ogawa Y.

Oncol Rep. 2011 Dec;26(6):1357-62. doi: 10.3892/or.2011.1445. Epub 2011 Sep 1.

PMID:
21887473
16.

Safety and effectiveness of a new enzyme-targeting radiosensitization treatment (KORTUC II) for intratumoral injection for low-LET radioresistant tumors.

Ogawa Y, Kubota K, Ue H, Tadokoro M, Matsui R, Yamanishi T, Hamada N, Kariya S, Nishioka A, Nakajima H, Tarutani M, Sano S.

Int J Oncol. 2011 Sep;39(3):553-60. doi: 10.3892/ijo.2011.1069. Epub 2011 Jun 6.

PMID:
21667020
17.

Diffusion-weighted imaging for parasternal lymph nodes in breast cancer: report of two cases.

Kataoka Y, Murata Y, Miyatake K, Tadokoro M, Nakatani K, Kubota K, Hamada N, Nishioka A, Ogawa Y.

Magn Reson Med Sci. 2011;10(1):53-7.

18.

Evaluation of Changes in Tumor Shadows and Microcalcifications on Mammography Following KORTUC II, a New Radiosensitization Treatment without any Surgical Procedure for Elderly Patients with Stage I and II Breast Cancer.

Tsuzuki A, Ogawa Y, Kubota K, Tokuhiro S, Akima R, Yaogawa S, Itoh K, Yamada Y, Sasaki T, Onogawa M, Yamanishi T, Kariya S, Nogami M, Nishioka A, Miyamura M.

Cancers (Basel). 2011 Sep 9;3(3):3496-505. doi: 10.3390/cancers3033496.

19.

Supplemental Content

Loading ...
Support Center